Zobrazeno 1 - 10
of 225
pro vyhledávání: '"L. B. A. Van de Putte"'
Publikováno v:
Tissue Antigens. 22:283-288
In 43 patients with pauciarticular and 26 patients with polyarticular juvenile chronic arthritis (JCA), an increased frequency was found for HLA-B27 (36%) in male patients with onset of the disease over 9 years of age. The antigen "DRw6" was observed
Autor:
Ivo Gut, Pilar Barrera, A. Lopes-Vaz, Thomas Bardin, Rene Westhovens, Vitor H. Teixeira, Helena Alves, Jeanine J. Houwing-Duistermaat, René E. M. Toes, S. Vrijmoet, Laëtitia Michou, P.L.C.M. van Riel, Twj Huizinga, Dora Pascual-Salcedo, Alejandro Balsa, Stefano Bombardieri, François Cornélis, Bernard Prum, Maria J.G. Fernandes, Trdj Radstake, L. B. A. Van De Putte, Carlos Vaz, Elisabeth Petit-Teixeira, Paola Migliorini, Dominique Rocha, Fina A S Kurreeman
Publikováno v:
Arthritis & rheumatology
Arthritis & rheumatology, 2008, 58 (9), pp.2670--2674. ⟨10.1002/art.23793⟩
Arthritis & rheumatology, Wiley, 2008, 58 (9), pp.2670--2674. ⟨10.1002/art.23793⟩
Arthritis and Rheumatism, 58, 2670-4
Arthritis and Rheumatism, 58, 9, pp. 2670-4
Arthritis & rheumatology, 2008, 58 (9), pp.2670--2674. ⟨10.1002/art.23793⟩
Arthritis & rheumatology, Wiley, 2008, 58 (9), pp.2670--2674. ⟨10.1002/art.23793⟩
Arthritis and Rheumatism, 58, 2670-4
Arthritis and Rheumatism, 58, 9, pp. 2670-4
Contains fulltext : 71178.pdf (Publisher’s version ) (Closed access) OBJECTIVE: We recently showed, using a candidate gene approach in a case-control association study, that a 65-kb block encompassing tumor necrosis factor receptor-associated facto
Publikováno v:
Annals of the Rheumatic Diseases. 65:1261-1264
A better insight into the realities behind osteoarthritis In this issue of the Annals of Rheumatic Diseases , Tan et al 1 report the results of high-resolution magnetic resonance imaging (hrMRI) of interphalangeal joints of 20 subjects who had “cli
Autor:
J Sany, L. B. A. Van De Putte, C Atkins, J. W. J. Bijlsma, N Walter, Michel Malaise, L. Settas, Peter Nash, S Fischkoff, M Kaul, S Todesco, Maxime Dougados, P.L.C.M. van Riel, H Kupper, Paul Emery, Anthony S. Russell
Publikováno v:
Annals of the Rheumatic Diseases. 63:508-516
Objective: To evaluate the efficacy and safety of monotherapy with adalimumab in patients with RA for whom previous DMARD treatment has failed. Methods: In a 26 week, double blind, placebo controlled, phase III trial, 544 patients with RA were random
Autor:
F.H.J. van den Hoogen, L. B. A. Van De Putte, A.M.M. Eijsbouts, C.G.J. Sweep, Roland Laan, Ad R. M. M. Hermus
Publikováno v:
Annals of the Rheumatic Diseases, 63, 433-437
Annals of the Rheumatic Diseases, 64, 433-7
Annals of the Rheumatic Diseases, 64, 3, pp. 433-7
Annals of the Rheumatic Diseases, 63, 3, pp. 433-437
Annals of the Rheumatic Diseases, 64, 433-7
Annals of the Rheumatic Diseases, 64, 3, pp. 433-7
Annals of the Rheumatic Diseases, 63, 3, pp. 433-437
Contains fulltext : 48358.pdf (Publisher’s version ) (Closed access) OBJECTIVE: To compare basal and stimulated prolactin levels between patients with rheumatoid arthritis and healthy controls, and to assess the effects of antirheumatic treatment o
Autor:
Daniel E. Furst, Maxime Dougados, Allan Gibofsky, J. R. Kalden, L. B. A. Van De Putte, Lars Klareskog, A F Kavenaugh, G.-R. Burmester, Paul Emery, F. C. Breedveld, Josef S. Smolen, E.C. Keystone, Anthony S. Russell, Michael H. Weisman
Publikováno v:
Annals of the Rheumatic Diseases. 62:2ii-9
As in previous years, the consensus group to consider the use of biological agents was constituted by rheumatologists from the Universities of Erlangen, Leiden, and Vienna in Europe in cooperation with universities in the United States, Canada, and E
Autor:
G.-R. Burmester, Haralampos M. Moutsopoulos, Henning Zeidler, J. R. Kalden, Ferdinand C. Breedveld, K. Beck, L. B. A. Van De Putte, M. Schattenkirchner, Michel Malaise, H Kupper, Paul Emery, Rolf Rau, P.L.C.M. van Riel
Publikováno v:
Annals of the Rheumatic Diseases, 62, 1168-77
Annals of the Rheumatic Diseases, 62, 12, pp. 1168-77
Annals of the Rheumatic Diseases, 62, 12, pp. 1168-77
Contains fulltext : 142630.pdf (Publisher’s version ) (Closed access) OBJECTIVES: To evaluate efficacy, dose response, safety, and tolerability of adalimumab (D2E7) in disease modifying antirheumatic drug (DMARD) refractory patients with longstandi
Autor:
L. B. A. Van De Putte, M.A. van Leeuwen, E.J.A. Kroot, F.H.J. van den Hoogen, M. H. Van Rijswijk, H.L. Swinkels, W. J. Van Venrooij, P.L.C.M. van Riel, M.A. van 't Hof, B. A. W. de Jong
Publikováno v:
ARTHRITIS AND RHEUMATISM, 43(8), 1831-1835. John Wiley and Sons Inc.
Arthritis and Rheumatism, 43, 1831-1835
Arthritis and Rheumatism, 43, pp. 1831-1835
Arthritis and Rheumatism, 43, 1831-1835
Arthritis and Rheumatism, 43, pp. 1831-1835
Objective To study the predictive value of anti–cyclic citrullinated peptide antibody (anti-CCP) in patients with recent-onset rheumatoid arthritis (RA). Methods Outcome in terms of physical disability (Health Assessment Questionnaire) and radiolog
Publikováno v:
Journal of Behavioral Medicine. 23:377-391
The objective of this study was to analyze the effect of coping with pain in rheumatoid arthritis (RA) on subsequent changes in psychological distress and disease impact. A sample of 109 randomly selected RA patients was asked to participate in a lon
Publikováno v:
Rheumatology. 38:415-422
Objectives. To study the familial aggregation of rheumatoid arthritis (RA) in The Netherlands and to analyse the effect of proband characteristics on the concordance rates for RA. Secondary aims were to compare the characteristics of patients in an e